Search Results
Slidesets
CRISPR/Cas and gene editing for HIV - Paula Cannon, PhD
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019
Slidesets
Non-Vaccine Oncogenic HPV Persistence Among HPV-Vaccinated Women Living with HIV - Elisabeth McClymont
Presented at:
International Workshop on HIV & Women 2019
Slidesets
Difficulties and barriers in developing RSV polymerase inhibitors | Rachel Fearns, PhD
Presented at:
RespiDART 2018
Slidesets
Abstract: Structure-based prediction of influenza resistance mutations (#102) | Bryan Cox
Presented at:
RespiDART 2018
Slidesets
Plasma tryptophan-kynurenine metabolites are altered with gut microbiota dysbiosis in HIV infection and associated with progression of carotid artery atherosclerosis- Qibin Qi, PhD
Presented at:
International Workshop on Microbiome in HIV Pathogenesis, Prevention and Treatment 2017
Slidesets
Case discussion: Co-morbidities in people living with HIV- Roger Paredes, MD, PhD
Presented at:
European Workshop on Healthy Living with HIV 2017
Slidesets
Trough dabrafenib plasma concentrations can predict occurrence of adverse effects requiring dose reduction in metastatic melanoma
Presented at:
International Workshop on Clinical Pharmacology of Anticancer Drugs (ICPAD) 2017
Slidesets
DDI’s in Aging HCV infected Patients- Elise Smolders, MSc
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2017
Slidesets
High dose rifampicin: a phase II trial comparing 10, 15 and 20 mg/kg rifampicin for two months - R. Aarnoutse
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2014
Slidesets
Next Generation Broadly Neutralizing Monoclonals - Lucio Gama, PhD
Presented at:
International Workshop on HIV Transmission 2021